What is Vibrant America Clinical Laboratory?
Vibrant America Clinical Laboratory is a prominent provider of diagnostic testing services, catering to patients, physicians, and hospitals nationwide. The company distinguishes itself through its specialization in advanced testing solutions, with a particular focus on autoimmune diagnostics. Leveraging cutting-edge technology and automated processes, Vibrant America ensures rapid turnaround times and high-quality, reliable results. Their commitment to innovation and affordability is further demonstrated by their web-based reporting system and accessible online portal for managing tests. The laboratory operates under CLIA and CAP certifications, guaranteeing the highest standards of quality and data security in its diagnostic operations.
How much funding has Vibrant America Clinical Laboratory raised?
Vibrant America Clinical Laboratory has raised a total of $2.1M across 2 funding rounds:
Debt
$1M
Debt
$1.1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.1M led by PPP
What's next for Vibrant America Clinical Laboratory?
The recent major strategic investment positions Vibrant America Clinical Laboratory for significant expansion and further technological advancement. With a foundation built on robust diagnostic capabilities and a commitment to quality, the company is poised to enhance its market presence. Future initiatives are likely to focus on scaling operations, expanding its specialized testing portfolio, and potentially integrating new diagnostic technologies to meet evolving healthcare demands. This capital infusion will be critical in supporting their mission to improve patient outcomes through accessible and innovative diagnostic solutions.
See full Vibrant America Clinical Laboratory company page
